These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11445882)

  • 1. Commercialization, patents and moral assessment of biotechnology products.
    Hoedemaekers R
    J Med Philos; 2001 Jun; 26(3):273-84. PubMed ID: 11445882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomedical patents and ethics: a Canadian solution.
    Gold ER
    McGill Law J; 2000 May; 45(2):413-35. PubMed ID: 12688288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locating gene patents within the patent system.
    Rai AK
    Am J Bioeth; 2002; 2(3):18-9. PubMed ID: 12230845
    [No Abstract]   [Full Text] [Related]  

  • 5. Actor-network theory: a tool to support ethical analysis of commercial genetic testing.
    Williams-Jones B; Graham JE
    New Genet Soc; 2003 Dec; 22(3):271-96. PubMed ID: 15115034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnology.
    Gold ER; Caulfield TA
    Lancet; 2002 Jun; 359(9325):2268-70. PubMed ID: 12103305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.
    Caulfield T; Ogbogu U
    Account Res; 2008; 15(4):303-20. PubMed ID: 18972268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotechnology and commodification within health care.
    Hanson MJ
    J Med Philos; 1999 Jun; 24(3):267-87. PubMed ID: 10472815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical limitations in patenting biotechnological inventions.
    Lugagnani V
    Forum (Genova); 1999; 9(3 Suppl 3):93-8. PubMed ID: 10607853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human genetic technology: who shall control?
    Blank RH
    Cornell J Soc Relat; 1984; 17(2):1-19. PubMed ID: 16100829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes and patent policy: rethinking intellectual property rights.
    Andrews LB
    Nat Rev Genet; 2002 Oct; 3(10):803-8. PubMed ID: 12360238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics, commodification, and social justice in the globalization era.
    Cahill LS
    Kennedy Inst Ethics J; 2001 Sep; 11(3):221-38. PubMed ID: 11700680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotechnological patents and ethical aspects.
    Ciliberti R
    Cancer Detect Prev; 1993; 17(2):313-5. PubMed ID: 8402718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 15. Religious voices in biotechnology: the case of gene patenting.
    Hanson MJ
    Genetic Resour; 1999; 12(1-2):5-22. PubMed ID: 12962106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The morality of biotech patents: differing legal obligations in Europe?
    Ford R
    Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biotechnology research and generation of patents of interest to the health system].
    Plaza Gómez L; Albert Martínez A
    Med Clin (Barc); 2008 Dec; 131 Suppl 5():55-9. PubMed ID: 19631824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Commercialization of genetic research and its impact on the communication of results].
    Cardinal G
    Health Law J; 1999; 7():35-48, 33. PubMed ID: 11066367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why ethics should be part of health technology assessment.
    Hofmann BM
    Int J Technol Assess Health Care; 2008; 24(4):423-9. PubMed ID: 18828936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotechnology and research: promise and problems.
    La Montagne JR
    Lancet; 2001 Nov; 358(9294):1723-4. PubMed ID: 11728568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.